Aspen Unscrambler HSI™

Solve complex problems with explorative, multivariate analysis of hyperspectral images. Everything you need for transformations, outlier detection and model validation to classify products and improve quality.

Get the Most Out of Every Pixel of Data

Easy to Use, All-in-One Product

Leverage powerful analytics, interactive visualizations and unique capabilities for spectroscopy and chemometrics to solve a range of complex problems across industries.

Better Analytical Insights

Use multivariate statistical analysis for HSI data to provide significantly more information from each model than generic image analysis tools.

Flexible Validation Options

Ensure your models are fit for purpose by validating them at the correct level with flexible options that provide valuable insights suited for your data.

Better Insights, Better Product Quality

Aspen Unscrambler HSI will take your insights to the next level by providing unprecedented information about composition and quality of every single product. From data analysis and predictive modeling to advanced raw materials testing and finalized product QA, now you can achieve higher quality and efficiency.

Related Products

Aspen Mtell

Aspen Mtell®

Get early and accurate warning of when an asset failure will occur, how the failure will occur and what to do about it.

Process Pulse

Aspen Process Pulse™

Monitor, control and optimize processes with real-time visibility of all types of process and spectral data.

Aspen ProMV

Aspen ProMV®

Identify the real underlying sources of variation in production processes that impact reliability and quality.


Aspen Unscrambler™

Model, predict and optimize processes using multivariate statistical analysis and interactive visualizations.

Whats new in V12.2
Accelerate digitalization to achieve sustainability goals and drive operational excellence.

Related Content

Webinar: How Ferring Automates Product Quality Control with an Online Spectroscopy Model

How a Multinational Biopharma Used PAT to Shift From Batch to Continuous Manufacturing

Pharma companies continue to strive for tight control of critical quality attributes (CQAs). When Ferring Pharmaceuticals wanted to move from batch to continuous manufacturing, they found that laborat...

On Demand Webinar
Webinar: Accelerate Market Growth with Process Analytical Technology (PAT)

Accelerate Market Growth with New Advances in Process Analytical Technology (PAT)

Pharmaceutical companies, CDMOs and CMOs face growing pressures to deliver more products at a lower cost while ensuring the quality and security of supply. Advanced PAT technologies address these chal...

On Demand Webinar
Accelerate Market Growth with New Advances in Process Analytical Technology (PAT)

Solution Brief: Accelerate Market Growth with New Advances in Process Analytical Technology

Pharmaceutical companies, CDMOs and CMOs continue to grapple with the tension between meeting the demand for increasingly diverse pharmaceutical products and the escalating challenges in ensuring supp...

White Paper
Article: Making the Journey to PAT and Pharma 4.0

Making the Journey to PAT and Pharma 4.0

In this article from European Pharmaceutical Review, David Leitham, Senior Vice President and General Manager at AspenTech®, explains how implementing PAT pushes the industry towards Pharma 4.0. Downl...

PAT Solution Webinar Series: Better Reaction Monitoring

Better Reaction Monitoring

While traditional reaction monitoring strategies have been effective at maintaining process safety and consistency, new developments are driving additional benefits like increased speed to market, red...

On Demand Webinar
PAT Solution Webinar Series: Better Batch Monitoring

Better Batch Monitoring

Batch processing requires supremely accurate monitoring to ensure successful batch completion. In the case of deviations, the ability to prevent unwanted process behavior from happening is critical to...

On Demand Webinar
PAT Solution Webinar Series: Better Blend Monitoring

Better Blend Monitoring

If faced with inhomogeneous blends, manufacturers lose money and valuable time. Not to mention the possible risks of reblends and regulatory citations.

On Demand Webinar